Nichols, D. E. & Walter, H. The history of psychedelics in psychiatry.
Pharmacopsychiatry
54
, 151–166 (2021).
Article
PubMed
Google Scholar
Davis, A. K. et al. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial.
JAMA Psychiatry
78
, 481–489 (2021).
Article
PubMed
Google Scholar
Carhart-Harris, R. et al. Trial of psilocybin versus escitalopram for depression.
N. Engl. J. Med.
384
, 1402–1411 (2021).
Article
CAS
PubMed
Google Scholar
Johnson, M. W., Garcia-Romeu, A. & Griffiths, R. R. Long-term follow-up of psilocybin-facilitated smoking cessation.
Am. J. Drug Alcohol Abuse
43
, 55–60 (2017).
Article
PubMed
Google Scholar
Nichols, D. E. Psychedelics.
Pharm. Rev.
68
, 264–355 (2016).
Article
CAS
PubMed
PubMed Central
Google Scholar
Vollenweider, F. X. & Preller, K. H. Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders.
Nat. Rev. Neurosci.
21
, 611–624 (2020).
Article
CAS
PubMed
Google Scholar
Kelmendi, B., Kaye, A. P., Pittenger, C. & Kwan, A. C. Psychedelics.
Curr. Biol.
32
, R63–R67 (2022).
Article
CAS
PubMed
Google Scholar
McClure-Begley, T. D. & Roth, B. L. The promises and perils of psychedelic pharmacology for psychiatry.
Nat. Rev. Drug Discov.
21
, 463–473 (2022).
Kim, K. et al. Structure of a hallucinogen-activated Gq-coupled 5-HT
2A
serotonin receptor.
Cell
182
, 1574–1588 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
Cao, D. et al. Structure-based discovery of nonhallucinogenic psychedelic analogs.
Science
375
, 403–411 (2022).
Article
CAS
PubMed
Google Scholar
Froldi, G., Silvestrin, B., Dorigo, P. & Caparrotta, L. Gramine: a vasorelaxing alkaloid acting on 5-HT
2A
receptors.
Planta Med.
70
, 373–375 (2004).
Article
CAS
PubMed
Google Scholar
Dong, C. et al. Psychedelic-inspired drug discovery using an engineered biosensor.
Cell
184
, 2779–2792 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Glennon, R. A., Liebowitz, S. M. & Mack, E. C. Serotonin receptor-binding affinities of several hallucinogenic phenylalkylamine and
N
,
N
-dimethyltryptamine analogs.
J. Med. Chem.
21
, 822–825 (1978).
Article
CAS
PubMed
Google Scholar
Lyon, R. A., Titeler, M., Seggel, M. R. & Glennon, R. A. Indolealkylamine analogs share 5-HT
2
binding characteristics with phenylalkylamine hallucinogens.
Eur. J. Pharmacol.
145
, 291–297 (1988).
Article
CAS
PubMed
Google Scholar
McLean, T. H. et al. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT
2A
receptor agonists.
J. Med. Chem.
49
, 5794–5803 (2006).
Article
CAS
PubMed
Google Scholar
Halberstadt, A. L., Chatha, M., Stratford, A., Grill, M. & Brandt, S. D. Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (‘FLY’) and benzodifuran (‘DragonFLY’) analogs.
Neuropharmacology
144
, 368–376 (2019).
Article
CAS
PubMed
Google Scholar
Mantle, T. J., Tipton, K. F. & Garrett, N. J. Inhibition of monoamine oxidase by amphetamine and related compounds.
Biochem. Pharmacol.
25
, 2073–2077 (1976).
Article
CAS
PubMed
Google Scholar
Glennon, R. A., Young, R. & Jacyno, J. M. Indolealkylamine and phenalkylamine hallucinogens—effect of α-methyl and
N
-methyl substituents on behavioral activity.
Biochem. Pharmacol.
32
, 1267–1273 (1983).
Article
CAS
PubMed
Google Scholar
Dyer, D. C., Nichols, D. E., Rusterholz, D. B. & Barfknecht, C. F. Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines.
Life Sci.
13
, 885–896 (1973).
Article
CAS
PubMed
Google Scholar
Congreve, M., Carr, R., Murray, C. & Jhoti, H. A ‘rule of three’ for fragment-based lead discovery?
Drug Discov. Today
8
, 876–877 (2003).
Article
PubMed
Google Scholar
Wager, T. T., Hou, X., Verhoest, P. R. & Villalobos, A. Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties.
ACS Chem. Neurosci.
1
, 435–449 (2010).
Article
CAS
PubMed
PubMed Central
Google Scholar
Takahashi, T. et al.
11
C labeling of indolealkylamine alkaloids and the comparative-study of their tissue distributions.
Int. J. Appl. Radiat. Isot.
36
, 965–969 (1985).
Article
CAS
PubMed
Google Scholar
Ebersole, B. J., Visiers, I., Weinstein, H. & Sealfon, S. C. Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT
2A
receptor determines relative efficacy.
Mol. Pharmacol.
63
, 36–43 (2003).
Article
CAS
PubMed
Google Scholar
Banskota, S., Ghia, J. E. & Khan, W. I. Serotonin in the gut: blessing or a curse.
Biochimie
161
, 56–64 (2019).
Article
CAS
PubMed
Google Scholar
Barfknecht, C. F. & Nichols, D. E. Correlation of psychotomimetic activity of phenethylamines and amphetamines with 1-octanol-water partition coefficients.
J. Med. Chem.
18
, 208–210 (1975).
Article
CAS
PubMed
Google Scholar
Perrin, D. D.
Dissociation Constants of Organic Bases in Aqueous Solution
(Butterworths, 1965).
Migliaccio, G. P., Shieh, T. L. N., Byrn, S. R., Hathaway, B. A. & Nichols, D. E. Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR-spectroscopy.
J. Med. Chem.
24
, 206–209 (1981).
Article
CAS
PubMed
Google Scholar
Adams, A. M. et al. In vivo production of psilocybin in
E. coli
.
Metab. Eng.
56
, 111–119 (2019).
Article
CAS
PubMed
Google Scholar
Milne, N. et al. Metabolic engineering of
Saccharomyces cerevisiae
for the de novo production of psilocybin and related tryptamine derivatives.
Metab. Eng.
60
, 25–36 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F., Babler, A., Vogel, H. & Hell, D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
NeuroReport
9
, 3897–3902 (1998).
Article
CAS
PubMed
Google Scholar
Preller, K. H. et al. The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation.
Curr. Biol.
27
, 451–457 (2017).
Article
CAS
PubMed
Google Scholar
Madsen, M. K. et al. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Neuropsychopharmacology
44
, 1328–1334 (2019).
Article
CAS
PubMed
PubMed Central
Google Scholar
Glennon, R. A., Titeler, M. & McKenney, J. D. Evidence for 5-HT
2
involvement in the mechanism of action of hallucinogenic agents.
Life Sci.
35
, 2505–2511 (1984).
Article
CAS
PubMed
Google Scholar
Halberstadt, A. L., Chatha, M., Klein, A. K., Wallach, J. & Brandt, S. D. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
Neuropharmacology
167
, 107933 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
Keiser, M. J. et al. Predicting new molecular targets for known drugs.
Nature
462
, 175–181 (2009).
Article
CAS
PubMed
PubMed Central
Google Scholar
Gonzalez-Maeso, J. et al. Hallucinogens recruit specific cortical 5-HT
2A
receptor-mediated signaling pathways to affect behavior.
Neuron
53
, 439–452 (2007).
Article
CAS
PubMed
Google Scholar
Kroeze, W. K. et al. PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome.
Nat. Struct. Mol. Biol.
22
, 362–369 (2015).
Article
CAS
PubMed
PubMed Central
Google Scholar
Marona-Lewicka, D., Thisted, R. A. & Nichols, D. E. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.
Psychopharmacology
180
, 427–435 (2005).
Article
CAS
PubMed
Google Scholar
Grailhe, R. et al. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT
5A
receptor.
Neuron
22
, 581–591 (1999).
Article
CAS
PubMed
Google Scholar
Marona-Lewicka, D., Chemel, B. R. & Nichols, D. E. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.
Psychopharmacology
203
, 265–277 (2009).
Article
CAS
PubMed
Google Scholar
Klein, A. K. et al. Investigation of the structure–activity relationships of psilocybin analogues.
ACS Pharm. Transl. Sci.
4
, 533–542 (2021).
Article
CAS
Google Scholar
Pokorny, T., Preller, K. H., Kraehenmann, R. & Vollenweider, F. X. Modulatory effect of the 5-HT
1A
agonist buspirone and the mixed non-hallucinogenic 5-HT
1A/2A
agonist ergotamine on psilocybin-induced psychedelic experience.
Eur. Neuropsychopharmacol.
26
, 756–766 (2016).
Article
CAS
PubMed
Google Scholar
Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B. & Thompson, S. M. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT
2R
activation in mice.
Proc. Natl Acad. Sci. USA
118
, e2022489118 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Shao, L. X. et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.
Neuron
109
, 2535–2544 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Sard, H. et al. SAR of psilocybin analogs: discovery of a selective 5-HT
2C
agonist.
Bioorg. Med. Chem. Lett.
15
, 4555–4559 (2005).
Article
CAS
PubMed
Google Scholar
Wacker, D. et al. Structural features for functional selectivity at serotonin receptors.
Science
340
, 615–619 (2013).
Article
CAS
PubMed
PubMed Central
Google Scholar
Wacker, D. et al. Crystal structure of an LSD-bound human serotonin receptor.
Cell
168
, 377–389 (2017).
Article
CAS
PubMed
PubMed Central
Google Scholar
Roth, B. L. Drugs and valvular heart disease.
N. Engl. J. Med.
356
, 6–9 (2007).
Article
CAS
PubMed
Google Scholar
Droogmans, S. et al. Possible association between 3,4-methylenedioxymethamphetamine abuse and valvular heart disease.
Am. J. Cardiol.
100
, 1442–1445 (2007).
Article
CAS
PubMed
Google Scholar
Setola, V. et al. 3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro.
Mol. Pharmacol.
63
, 1223–1229 (2003).
Article
CAS
PubMed
Google Scholar
Roth, B. L., Nakaki, T., Chuang, D. M. & Costa, E. Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover.
Neuropharmacology
23
, 1223–1225 (1984).
Article
CAS
PubMed
Google Scholar
Roth, B. L., Nakaki, T., Chuang, D. M. & Costa, E. 5-Hydroxytryptamine 2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester.
J. Pharmacol. Exp. Ther.
238
, 480–485 (1986).
CAS
PubMed
Google Scholar
Kristiansen, K. et al. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT
2A
serotonin receptor but does not participate in activation via a ‘salt-bridge disruption’ mechanism.
J. Pharmacol. Exp. Ther.
293
, 735–746 (2000).
CAS
PubMed
Google Scholar
Egan, C. et al. Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT
2A
and 5-HT
2C
receptors.
Synapse
35
, 144–150 (2000).
Article
CAS
PubMed
Google Scholar
Gray, J. A., Bhatnagar, A., Gurevich, V. V. & Roth, B. L. The interaction of a constitutively active arrestin with the arrestin-insensitive 5-HT
2A
receptor induces agonist-independent internalization.
Mol. Pharmacol.
63
, 961–972 (2003).
Article
CAS
PubMed
Google Scholar
Felder, C. C., Kanterman, R. Y., Ma, A. L. & Axelrod, J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis.
Proc. Natl Acad. Sci. USA
87
, 2187–2191 (1990).
Article
CAS
PubMed
PubMed Central
Google Scholar
Garcia, E. E., Smith, R. L. & Sanders-Bush, E. Role of G
q
protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
Neuropharmacology
52
, 1671–1677 (2007).
Article
CAS
PubMed
PubMed Central
Google Scholar
Schmid, C. L., Raehal, K. M. & Bohn, L. M. Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo.
Proc. Natl Acad. Sci. USA
105
, 1079–1084 (2008).
Article
CAS
PubMed
PubMed Central
Google Scholar
Rodriguiz, R. M. et al. LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1.
Sci. Rep.
11
, 17690 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Kurrasch-Orbaugh, D. M., Parrish, J. C., Watts, V. J. & Nichols, D. E. A complex signaling cascade links the serotonin 2A receptor to phospholipase A2 activation: the involvement of MAP kinases.
J. Neurochem.
86
, 980–991 (2003).
Article
CAS
PubMed
Google Scholar
Zhuang, Y. et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes.
Cell
184
, 931–942 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Hasler, F., Bourquin, D., Brenneisen, R., Bar, T. & Vollenweider, F. X. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.
Pharm. Acta Helv.
72
, 175–184 (1997).
Article
CAS
PubMed
Google Scholar
Brandt, S. D. et al. Return of the lysergamides. Part I: analytical and behavioural characterization of 1-propionyl-
d
-lysergic acid diethylamide (1P-LSD).
Drug Test. Anal.
8
, 891–902 (2016).
Article
CAS
PubMed
Google Scholar
Vargas, M. V., Meyer, R., Avanes, A. A., Rus, M. & Olson, D. E. Psychedelics and other psychoplastogens for treating mental illness.
Front. Psychiatry
12
, 727117 (2021).
Article
PubMed
PubMed Central
Google Scholar
Olson, D. E. Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics.
J. Exp. Neurosci.
12
, 1179069518800508 (2018).
Article
PubMed
PubMed Central
Google Scholar
Dunlap, L. E. et al. Identification of psychoplastogenic
N
,
N
-dimethylaminoisotryptamine (isoDMT) analogues through structure–activity relationship studies.
J. Med. Chem.
63
, 1142–1155 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
Cameron, L. P. et al. A non-hallucinogenic psychedelic analogue with therapeutic potential.
Nature
589
, 474–479 (2020).
Lyu, J. et al. Ultra-large library docking for discovering new chemotypes.
Nature
566
, 224–229 (2019).
Article
CAS
PubMed
PubMed Central
Google Scholar
Sadybekov, A. A. et al. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds.
Nature
601
, 452–459 (2022).
Article
CAS
PubMed
Google Scholar
Araneda, R. & Andrade, R. 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex.
Neuroscience
40
, 199–412 (1991).
Article
Google Scholar
Davies, M. F., Deisz, R. A., Prince, D. A. & Peroutka, S. J. Two distinct effects of 5-hydroxytryptamine on single cortical neurons.
Brain Res.
423
, 347–352 (1987).
Article
CAS
PubMed
Google Scholar
Savalia, N. K., Shao, L. X. & Kwan, A. C. A dendrite-focused framework for understanding the actions of ketamine and psychedelics.
Trends Neurosci.
44
, 260–275 (2021).
Article
CAS
PubMed
Google Scholar
Miner, L. A. H., Backstrom, J. R., Sanders-Bush, E. & Sesack, S. R. Ultrastructural localization of serotonin 2a receptors in the middle layers of the rat prelimibic prefrontal cortex.
Neuroscience
116
, 107–117 (2003).
Article
CAS
PubMed
Google Scholar
Jakab, R. L. & Goldman-Rakic, P. S. 5-Hydroxytryptamine 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites.
Proc. Natl Acad. Sci. USA
95
, 735–740 (1998).
Article
CAS
PubMed
PubMed Central
Google Scholar
Willins, D. L., Deutch, A. Y. & Roth, B. L. Serotonin 5-HT
2A
receptors are expressed on pyramidal cells and interneurons in the rat cortex.
Synapse
27
, 79–82 (1997).
Article
CAS
PubMed
Google Scholar
Aghajanian, G. K. & Marek, G. J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.
Neuropharmacology
36
, 589–599 (1997).
Article
CAS
PubMed
Google Scholar
Santana, N., Bortolozzi, A., Serrats, J., Mengod, G. & Artigas, F. Expression of serotonin 1A and serotonin 2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex.
Cereb. Cortex
14
, 1100–1109 (2004).
Article
PubMed
Google Scholar
Martin, D. A. & Nichols, C. D. Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain.
EBioMedicine
11
, 262–277 (2016).
Article
PubMed
PubMed Central
Google Scholar
Avesar, D. & Gulledge, A. T. Selective serotonergic excitation of callosal projection neurons.
Front. Neural Circuits
6
, 12 (2012).
Article
PubMed
PubMed Central
Google Scholar
Wood, J., Kim, Y. & Moghaddam, B. Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs.
J. Neurosci.
32
, 3022–3031 (2012).
Article
CAS
PubMed
PubMed Central
Google Scholar
Evarts, E. V., Landau, W., Freygang, W. Jr. & Marshall, W. H. Some effects of lysergic acid diethylamide and bufotenine.
Am. J. Physiol.
182
, 594–598 (1955).
Article
CAS
PubMed
Google Scholar
Rose, D. & Horn, G. Effects of LSD on the responses of single units in cat visual cortex.
Exp. Brain Res.
27
, 71–80 (1977).
Article
CAS
PubMed
Google Scholar
Michaiel, A. M., Parker, P. R. L. & Niell, C. M. A hallucinogenic serotonin-2A receptor agonist reduces visual response gain and alters temporal dynamics in mouse V1.
Cell Rep.
26
, 3475–3483 (2019).
Article
CAS
PubMed
PubMed Central
Google Scholar
Aghajanian, G. K., Foote, W. E. & Sheard, M. H. Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe.
Science
161
, 706–708 (1968).
Article
CAS
PubMed
Google Scholar
Aghajanian, G. K., Foote, W. E. & Sheard, M. H. Action of psychotogenic drugs on single midbrain raphe neurons.
J. Pharmacol. Exp. Ther.
171
, 178–187 (1970).
CAS
PubMed
Google Scholar
Sprouse, J. S. & Aghajanian, G. K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT
1A
and 5-HT
1B
agonists.
Synapse
1
, 3–9 (1987).
Article
CAS
PubMed
Google Scholar
Trulson, M. E., Ross, C. A. & Jacobs, B. L. Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide.
Neuropharmacology
16
, 771–774 (1977).
Article
CAS
PubMed
Google Scholar
Trulson, M. E. & Jacobs, B. L. Dissociations between the effects of LSD on behavior and raphe unit-activity in freely moving cats.
Science
205
, 515–518 (1979).
Article
CAS
PubMed
Google Scholar
Domenico, C., Haggerty, D., Mou, X. & Ji, D. LSD degrades hippocampal spatial representations and suppresses hippocampal–visual cortical interactions.
Cell Rep.
36
, 109714 (2021).
Article
CAS
PubMed
Google Scholar
Rasmussen, K. & Aghajanian, G. K. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT
2
antagonists.
Brain Res.
385
, 395–400 (1986).
Article
CAS
PubMed
Google Scholar
Aghajanian, G. K. LSD and CNS transmission.
Annu. Rev. Pharm.
12
, 157–168 (1972).
Article
CAS
Google Scholar
Nichols, C. D. & Sanders-Bush, E. A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain.
Neuropsychopharmacology
26
, 634–642 (2002).
Article
CAS
PubMed
Google Scholar
Vaidya, V. A., Marek, G. J., Aghajanian, G. K. & Duman, R. S. 5-HT
2A
receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex.
J. Neurosci.
17
, 2785–2795 (1997).
Article
CAS
PubMed
PubMed Central
Google Scholar
de la Fuente Revenga, M. et al. Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice.
Cell Rep.
37
, 109836 (2021).
Article
PubMed
Google Scholar
Jones, K. A. et al. Rapid modulation of spine morphology by the 5-HT
2A
serotonin receptor through kalirin-7 signaling.
Proc. Natl Acad. Sci. USA
106
, 19575–19580 (2009).
Article
CAS
PubMed
PubMed Central
Google Scholar
Yoshida, H. et al. Subtype specific roles of serotonin receptors in the spine formation of cortical neurons in vitro.
Neurosci. Res.
71
, 311–314 (2011).
Article
CAS
PubMed
Google Scholar
Ly, C. et al. Psychedelics promote structural and functional neural plasticity.
Cell Rep.
23
, 3170–3182 (2018).
Article
CAS
PubMed
PubMed Central
Google Scholar
Raval, N. R. et al. A single dose of psilocybin increases synaptic density and decreases 5-HT
2A
receptor density in the pig brain.
Int. J. Mol. Sci.
22
, 835 (2021).
Article
CAS
PubMed Central
Google Scholar
Ly, C. et al. Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth.
ACS Pharmacol. Transl. Sci.
4
, 452–460 (2020).
Phoumthipphavong, V., Barthas, F., Hassett, S. & Kwan, A. C. Longitudinal effects of ketamine on dendritic architecture in vivo in the mouse medial frontal cortex.
eNeuro
3
, ENEURO.0133-0115.2016 (2016).
Ali, F. et al. Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines.
Nat. Commun.
11
, 72 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
Aleksandrova, L. R. & Phillips, A. G. Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
Trends Pharmacol. Sci.
42
, 929–942 (2021).
Article
CAS
PubMed
Google Scholar
Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K. & Nichols, C. D. Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression.
ACS Chem. Neurosci.
11
, 864–871 (2020).
Article
CAS
PubMed
Google Scholar
Hermle, L. et al. Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: experimental psychosis as a tool for psychiatric research.
Biol. Psychiatry
32
, 976–991 (1992).
Article
CAS
PubMed
Google Scholar
Vollenweider, F. X. et al. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.
Neuropsychopharmacology
16
, 357–372 (1997).
Article
CAS
PubMed
Google Scholar
Carhart-Harris, R. L. et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
Proc. Natl Acad. Sci. USA
109
, 2138–2143 (2012).
Article
CAS
PubMed
PubMed Central
Google Scholar
Lewis, C. R. et al. Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.
NeuroImage
159
, 70–78 (2017).
Article
CAS
PubMed
Google Scholar
Preller, K. H. et al. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT
2A
receptor.
eLife
7
, e35082 (2018).
Article
PubMed
PubMed Central
Google Scholar
Muller, F., Dolder, P. C., Schmidt, A., Liechti, M. E. & Borgwardt, S. Altered network hub connectivity after acute LSD administration.
NeuroImage Clin.
18
, 694–701 (2018).
Article
PubMed
PubMed Central
Google Scholar
Madsen, M. K. et al. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.
Eur. Neuropsychopharmacol.
50
, 121–132 (2021).
Article
CAS
PubMed
Google Scholar
Preller, K. H. et al. Psilocybin induces time-dependent changes in global functional connectivity.
Biol. Psychiatry
88
, 197–207 (2020).
Article
CAS
PubMed
Google Scholar
Muller, F. et al. Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations.
Acta Psychiatr. Scand.
136
, 648–657 (2017).
Article
CAS
PubMed
PubMed Central
Google Scholar
Preller, K. H. et al. Effective connectivity changes in LSD-induced altered states of consciousness in humans.
Proc. Natl Acad. Sci. USA
116
, 2743–2748 (2019).
Article
PubMed
PubMed Central
Google Scholar
Hawrylycz, M. J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome.
Nature
489
, 391–399 (2012).
Article
CAS
PubMed
PubMed Central
Google Scholar
Beliveau, V. et al. A high-resolution in vivo atlas of the human brain’s serotonin system.
J. Neurosci.
37
, 120–128 (2017).
Article
CAS
PubMed
PubMed Central
Google Scholar
Deco, G. et al. Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD.
Curr. Biol.
28
, 3065–3074 (2018).
Article
CAS
PubMed
Google Scholar
Burt, J. B. et al. Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD.
eLife
10
, e69320 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Kringelbach, M. L. et al. Dynamic coupling of whole-brain neuronal and neurotransmitter systems.
Proc. Natl Acad. Sci. USA
117
, 9566–9576 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
McCulloch, D. E. et al. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.
J. Psychopharmacol.
36
, 74–84 (2022).
Article
CAS
PubMed
Google Scholar
Barrett, F. S., Doss, M. K., Sepeda, N. D., Pekar, J. J. & Griffiths, R. R. Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Sci. Rep.
10
, 2214 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
Doss, M. K. et al. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.
Transl. Psychiatry
11
, 574 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Daws, R. E. et al. Increased global integration in the brain after psilocybin therapy for depression.
Nat. Med.
28
, 844–851 (2022).
Article
CAS
PubMed
Google Scholar
Stenbaek, D. S. et al. Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans.
J. Psychopharmacol.
35
, 459–468 (2021).
Article
CAS
PubMed
Google Scholar
Vollenweider, F. X. & Geyer, M. A. A systems model of altered consciousness: integrating natural and drug-induced psychoses.
Brain Res. Bull.
56
, 495–507 (2001).
Article
CAS
PubMed
Google Scholar
Carhart-Harris, R. L. & Friston, K. J. REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics.
Pharm. Rev.
71
, 316–344 (2019).
Article
CAS
PubMed
PubMed Central
Google Scholar
Corlett, P. R. et al. Hallucinations and strong priors.
Trends Cogn. Sci.
23
, 114–127 (2019).
Article
PubMed
Google Scholar
Doss, M. K. et al. Models of psychedelic drug action: modulation of cortical–subcortical circuits.
Brain
145
, 441–456 (2021).
Vollenweider, F. X., Csomor, P. A., Knappe, B., Geyer, M. A. & Quednow, B. B. The effects of the preferential 5-HT
2A
agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval.
Neuropsychopharmacology
32
, 1876–1887 (2007).
Article
CAS
PubMed
Google Scholar
Schmid, Y. et al. Acute effects of lysergic acid diethylamide in healthy subjects.
Biol. Psychiatry
78
, 544–553 (2015).
Article
CAS
PubMed
Google Scholar
Roseman, L. et al. LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.
Hum. Brain Mapp.
37
, 3031–3040 (2016).
Article
PubMed
PubMed Central
Google Scholar
Schartner, M. M., Carhart-Harris, R. L., Barrett, A. B., Seth, A. K. & Muthukumaraswamy, S. D. Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.
Sci. Rep.
7
, 46421 (2017).
Article
CAS
PubMed
PubMed Central
Google Scholar
Timmermann, C. et al. Neural correlates of the DMT experience assessed with multivariate EEG.
Sci. Rep.
9
, 16324 (2019).
Article
PubMed
PubMed Central
Google Scholar
Alamia, A., Timmermann, C., Nutt, D. J., VanRullen, R. & Carhart-Harris, R. L. DMT alters cortical travelling waves.
eLife
9
, e59784 (2020).
Article
CAS
PubMed
PubMed Central
Google Scholar
Vernon, J., Marton, T. & Peterson, E. Sensory deprivation and hallucinations.
Science
133
, 1808–1812 (1961).
Article
CAS
PubMed
Google Scholar
Powers, A. R., Mathys, C. & Corlett, P. R. Pavlovian conditioning-induced hallucinations result from overweighting of perceptual priors.
Science
357
, 596–600 (2017).
Article
CAS
PubMed
PubMed Central
Google Scholar
Barrett, F. S., Krimmel, S. R., Griffiths, R. R., Seminowicz, D. A. & Mathur, B. N. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.
NeuroImage
218
, 116980 (2020).
Article
CAS
PubMed
Google Scholar
Smith, R. L., Barrett, R. J. & Sanders-Bush, E. Neurochemical and behavioral evidence that quipazine–ketanserin discrimination is mediated by serotonin 2A receptor.
J. Pharmacol. Exp. Ther.
275
, 1050–1057 (1995).
CAS
PubMed
Google Scholar
Palacios, J. M., Pazos, A. & Hoyer, D. A short history of the 5-HT
2C
receptor: from the choroid plexus to depression, obesity and addiction treatment.
Psychopharmacology
234
, 1395–1418 (2017).
Article
CAS
PubMed
Google Scholar
Fitzgerald, L. W. et al. Messenger RNA editing of the human serotonin 5-HT
2C
receptor.
Neuropsychopharmacology
21
, 82S–90S (1999).
Article
CAS
PubMed
Google Scholar
Casey, A. B., Cui, M., Booth, R. G. & Canal, C. E. ‘Selective’ serotonin 5-HT
2A
receptor antagonists.
Biochem. Pharmacol.
200
, 115028 (2022).
Article
CAS
PubMed
Google Scholar
Robinson, T. E. & Kolb, B. Structural plasticity associated with exposure to drugs of abuse.
Neuropharmacology
47
, 33–46 (2004).
Article
CAS
PubMed
Google Scholar
Bittner, T. et al. γ-Secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway.
J. Neurosci.
29
, 10405–10409 (2009).
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang, K. W. et al. Molecular and anatomical organization of the dorsal raphe nucleus.
eLife
8
, e46464 (2019).
Article
PubMed
PubMed Central
Google Scholar
Olson, D. E. The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects.
ACS Pharmacol. Transl. Sci.
4
, 563–567 (2020).
Article
PubMed
PubMed Central
Google Scholar
Yaden, D. B. & Griffiths, R. R. The subjective effects of psychedelics are necessary for their enduring therapeutic effects.
ACS Pharmacol. Transl. Sci.
4
, 568–572 (2020).
Osmond, H. A review of the clinical effects of psychotomimetic agents.
Ann. N. Y. Acad. Sci.
66
, 418–434 (1957).
Article
CAS
PubMed
Google Scholar
Shulgin, A. & Shulgin, A.
PIHKAL: A Chemical Love Story
(Transform, 1990).
Shulgin, A. & Shulgin, A.
TiHKAL: The Continuation
(Transform, 2002).
Griffiths, R. R., Richards, W. A., McCann, U. & Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
Psychopharmacology
187
, 268–283 (2006).
Article
CAS
PubMed
Google Scholar
Griffiths, R. R. et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial.
J. Psychopharmacol.
30
, 1181–1197 (2016).
Article
CAS
PubMed
PubMed Central
Google Scholar
Abramson, H. A.
The Use of LSD in Psychotherapy and Alcoholism
(Bobbs–Merrill, 1967).
Grob, C. S. et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Arch. Gen. Psychiatry
68
, 71–78 (2011).
Article
CAS
PubMed
Google Scholar
Ross, S. et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
J. Psychopharmacol.
30
, 1165–1180 (2016).
Article
CAS
PubMed
PubMed Central
Google Scholar
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S. & Duman, R. S. Ketamine: a paradigm shift for depression research and treatment.
Neuron
101
, 774–778 (2019).
Article
CAS
PubMed
PubMed Central
Google Scholar
Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Nat. Med.
27
, 1025–1033 (2021).
Article
CAS
PubMed
PubMed Central
Google Scholar
Canal, C. E. & Morgan, D. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.
Drug Test. Anal.
4
, 556–576 (2012).
Article
CAS
PubMed
PubMed Central
Google Scholar
Appel, J. B., West, W. B. & Buggy, J. LSD, 5-HT (serotonin), and the evolution of a behavioral assay.
Neurosci. Biobehav. Rev.
27
, 693–701 (2004).
Article
CAS
PubMed
Google Scholar